Trade Summary

1 week ago, Kalif Eliyahu Sharon, serving as EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 106,563 shares at $34.10 per share, for a total transaction value of $3,633,308.11. Following this transaction, Kalif Eliyahu Sharon now holds 65,621 shares of TEVA.

This sale represents a 61.89% decrease in Kalif Eliyahu Sharon's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 11, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 16, 2026 at 8:28 AM ET, 5 days after the trade was made.

TEVA PHARMACEUTICAL INDUSTRIES LTD operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.